Effect of Age on Clinical Trial Outcome in Participants with Probable Alzheimer's Disease.

J Alzheimers Dis · 2021 · PMC8461716 · PMID 34151817

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

In the cohort≥65 years old ( n = 30), all of the clinical metrics and glucose metabolism measures favored DBS-f “on” treatment over the DBS-f “off” sham treatment after 12 months, although the difference did not reach statistical significance [ 6 ].

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.